SELECT was a large study focused on obesity and cardiovascular disease in people without type 2 diabetes, but it included kidney outcomes as a secondary end point. The data showed that semaglutide ...

Dr. Daniel Meltzer, an ER physician, says diabetes and high blood pressure are two leading causes of kidney dysfunction.

Diabetes is one of the leading causes of kidney disease worldwide, and the damage often develops silently over time.

Weekly injections of semaglutide medications like Ozempic significantly reduce the risk of serious kidney outcomes, major cardiovascular events and death among people who have type 2 diabetes and ...

Diabetes is one of the leading causes of kidney disease worldwide, and India carries a particularly high burden of both conditions. What makes diabetic kidney disease especially concerning is that it ...

The nonsteroidal mineralocorticoid receptor antagonist finerenone has been reported to improve kidney and cardiovascular outcomes in persons with type 2 diabetes and chronic kidney disease (CKD).

"This is the first GLP-1 receptor agonists study to show significant reduction in the risk of kidney failure…Our study establishes GLP-1 receptor agonists as an important kidney-protective class of ...

People with both type 2 diabetes and chronic kidney disease face a heart health double-whammy, a new study says. Men with both diabetes and kidney disease will develop heart health problems 28 years ...

Share on Pinterest New research indicates that people with CKM syndrome may have a higher risk of developing cardiovascular disease up to 28 years earlier. Marko Cvetkovic/Getty Images New research ...